Braxia Scientific Corp.
BRAXF · OTC
3/31/2023 | 3/31/2022 | 3/31/2021 | 3/31/2020 | |
|---|---|---|---|---|
| Market Cap | $5,897 | $10,517 | $75,248 | $22,732 |
| - Cash | $1,462 | $8,678 | $11,101 | $1,520 |
| + Debt | $207 | $217 | $108 | $11 |
| Enterprise Value | $4,641 | $2,057 | $64,255 | $21,223 |
| Revenue | $1,884 | $1,487 | $1,008 | $0 |
| % Growth | 26.7% | 47.5% | 475,547.2% | – |
| Gross Profit | $172 | -$3,282 | -$2,891 | -$9 |
| % Margin | 9.1% | -220.7% | -286.7% | -4,219.8% |
| EBITDA | -$12,704 | -$7,136 | -$88,805 | -$3,298 |
| % Margin | -674.2% | -479.9% | -8,806.8% | -1,555,754.2% |
| Net Income | -$13,142 | -$12,134 | -$88,828 | -$173 |
| % Margin | -697.5% | -815.9% | -8,809.1% | -81,473.1% |
| EPS Diluted | -0.058 | -0.069 | -0.56 | -0.004 |
| % Growth | 16.9% | 87.6% | -12,627.3% | – |
| Operating Cash Flow | -$7,399 | -$4,518 | -$5,056 | -$289 |
| Capital Expenditures | -$903 | -$25 | -$22 | -$60 |
| Free Cash Flow | -$8,302 | -$4,544 | -$5,078 | -$349 |